Prevalence of Plasmid-Mediated Quinolone Resistance Genes and Ciprofloxacin Resistance in Pediatric Bloodstream Isolates of Enterobacteriaceae over a 9-Year Period

Japanese Journal of Infectious Diseases

Volumn 66, Issue 2, 2013, Pages 151-154

  Kim, Nam Hee ^a,b   Choi, Eun Hwa ^a,c   Sung, Ji Yeon ^a   Oh, Chi Eun ^d   Kim, Hong Bin ^c   Kim, Eui Chong ^a   Lee, Hoan Jong ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Ilsanpaik Hospital   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

^d Kosin University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; QUINOLONE;

ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD SAMPLING; CONTROLLED STUDY; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GENE MUTATION; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEDIATRIC HOSPITAL; PLASMID MEDIATED QUINOLONE RESISTANCE GENE; PREVALENCE; SOUTH KOREA;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BACTEREMIA; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; HUMANS; INFANT; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PLASMIDS; QUINOLONES; REPUBLIC OF KOREA;

EID: 84875280201     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: 10.7883/yoken.66.151     Document Type: Article

References (18)

1. Hooper, D.C. (1992): Mechanisms of fluoroquinolone resistance. Drug Resist. Updat., 2, 38-55.
2. Jacoby, G.A., Cattoir, V., Hooper, D.C., et al. (2008): Qnr gene nomenclature. Antimicrob. Agents Chemother., 52, 2297-2299.
3. Strahilevitz, J., Jacoby, G.A., Hooper, D.C., et al. (2009): Plasmid-mediated quinolone resistance: a multifaceted threat. Clin. Microbiol. Rev., 22, 664-689.
4. Wang, A., Yang, Y., Lu, Q., et al. (2008): Occurrence of qnrpositive clinical isolates in Klebsiella pneumoniae producing ESBL or AmpC-type β-lactamase from five pediatric hospitals in China. FEMS Microbiol. Lett., 283, 112-116.
5. Han, C., Yang, Y., Wang, M., et al. (2010): The prevalence of plasmid-mediated quinolone resistance determinants among clinical isolates of ESBL or AmpC-producing Escherichia coli from Chinese pediatric patients. Microbiol. Immunol., 54, 123-128.
6. García-Fulgueiras, V., Bado, I., Mota, M.I., et al. (2011): Extended-spectrum β-lactamases and plasmid-mediated quinolone resistance in enterobacterial clinical isolates in the paediatric hospital of Uruguay. J. Antimicrob. Chemother., 66, 1725-1729.
7. Kim, H.B., Park, C.H., Kim, C.J., et al. (2009): Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob. Agents Chemother., 53, 639-645.
8. Périchon, B., Courvalin, P. and Galimand, M. (2007): Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli. Antimicrob. Agents Chemother., 51, 2464-2469.
9. Robicsek, A., Strahilevitz, J., Sahm, D.F., et al. (2006): Qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob. Agents Chemother., 50, 2872-2874.
10. Park, C.H., Robicsek, A., Jacoby, G.A., et al. (2006): Prevalence in the United States of aac(6?)-Iβ-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob. Agents Chemother., 50, 3953-3955.
11. Clinical and Laboratory Standards Institute (CLSI) (2007): Performance Standards for Antimicrobial Susceptibility Testing-15th Informational Supplement: Approved Standard M100-S15. CLSI, Wayne, Pa., USA.
12. Patterson, J.E., Hardin, T.C., Kelly, C.A., et al. (2000): Association of antibiotic utilization measures and control of multipledrug resistance in Klebsiella pneumoniae. Infect. Control Hosp. Epidemiol., 21, 455-458.
13. Robicsek, A., Strahilevitz, J., Jacoby, G.A., et al. (2006): Fluoroquinolone modifying enzyme: a novel adaptation of a common aminoglycoside acetyltransferase. Nature Med., 12, 83-88.
14. Martinez-Martinez, L., Pascual, A. and Jacoby, G.A. (1988): Quinolone resistance from a transferable plasmid. Lancet, 351, 797-799.
15. Perichon, B., Tankovic, J. and Courvalin, P. (1997): Characterization of a mutation in the parE gene that confers fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother., 41, 1166-1167.
16. Kim, H.B., Wang, M., Park, C.H., et al. (2009): oqxAB encoding a multidrug efflux pump in human clinical isolates of Enterobacteriaceae. Antimicrob. Agents Chemother., 53, 3582-3584.
17. Rodríguez-Martínez, J.M., Velasco, C., Pascual, A., et al. (2006): Correlation of quinolone resistance levels and differences in basal and quinolone-induced expression from three qnrA-containing plasmids. Clin. Microbiol. Infect., 12, 440-445.
18. Rodríguez-Martínez, J.M., Velasco, C., Garcia, I., et al. (2007): Mutant prevention concentrations of fluoroquinolones for Enterobacteriaceae expressing the plasmid-carried quinolone resistance determinant qnrA1. Antimicrob. Agents Chemother., 51, 2236-2239.